《大行报告》美银证券下调康基医疗(09997.HK)评级至「跑输大市」 目标价削至9.4元
美银证券发表报告指,康基医疗(09997.HK)去年收入为5.12亿元人民币,按年增长1.6%,逊於该行预测6%。特别是聚合物结?夹收入仅增长10.2%,而一次性套管针的收入更减少5.3%。
该行表示,集团核心产品的增长疲弱,主要是由於手术复苏缓慢,及来自同行的竞争,例如南京的集中采购。
美银下调康基医疗股份评级,由「中性」降至「跑输大市」,目标价由15.31元削至9.4元,并调低集团今明两年收入预测分别6%及8%,盈利预测亦下调8%及9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.